Pascack Bancorp Inc (PSBR) 10.9500 $PSBR Lakeland

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pascack Bancorp Inc (PSBR) 10.9500 $PSBR

Lakeland Bancorp Reports First Quarter 2016 Earnings and Increases Cash Dividend
GlobeNewswire - Tue Apr 26, 8:04AM CDT
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results for the quarter ended March 31, 2016:
LBAI: 11.44 (+0.30)

Bancorp of New Jersey, Inc. Announces Nancy E. Graves as New President and Chief Executive Officer and a Member of the Board
GlobeNewswire - Tue Apr 05, 4:16PM CDT
Bancorp of New Jersey, Inc. (NYSE MKT:BKJ), the holding company of Bank of New Jersey, today announced the appointment of Nancy E. Graves as the new President and Chief Executive Officer of the holding company and the bank. Ms. Graves, who recently served as President and CEO of Pascack Bancorp, Inc. and Pascack Community Bank, has also been appointed to the boards of directors of the Bancorp of New Jersey, Inc. and Bank of New Jersey. Gerald A. Calabrese, Jr., Chairman of the Board, had been serving as interim chief executive officer and president.
BKJ: 11.14 (-0.21)

Lakeland Bancorp Reports Record Full Year Results and Closes Pascack Bancorp Acquisition
GlobeNewswire - Thu Jan 28, 8:28AM CST
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results for the fourth quarter of 2015 and for the year ended December 31, 2015:
LBAI: 11.44 (+0.30)

Lakeland Bancorp Third Quarter Results Driven by Strong Loan Growth; Receives Regulatory Approvals for Merger with Pascack Bancorp
GlobeNewswire - Tue Oct 27, 8:18AM CDT
Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the "Company" reported the following results in the third quarter of 2015:
LBAI: 11.44 (+0.30)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pascack Bancorp, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Lakeland Bancorp, Inc.
BusinessWire - Fri Aug 07, 8:28AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
LBAI: 11.44 (+0.30)

Lifshitz & Miller Law Firm Announces Investigation of Cigna Corporation, Cytec Industries Inc., Ikanos Communications, Inc., IPC Healthcare Inc., Magnetek Inc., Pascack Bancorp, Inc., StanCorp Financial Group Inc., and Tecumseh Products Company
PR Newswire - Thu Aug 06, 11:57AM CDT
Cigna Corporation
CI: 129.60 (+2.60), MAG: 14.73 (+0.58), ANTM: 132.15 (+2.71), IKAN: 2.74 (unch), SFG: 114.97 (-0.01), IPCM: 80.17 (+0.01), CYT: 75.17 (+0.02), TECU: 4.99 (-0.01)

PASCACK BANCORP, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Lakeland Bancorp, Inc.
BusinessWire - Thu Aug 06, 11:51AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Pascack Bancorp, Inc. ("Pascack" (OTCMKTS: PSBR) concerning the sale to Lakeland Bancorp, Inc. Under the terms of the agreement, Pascack shareholders will receive either 0.9576 shares of Lakeland Bancorp (NasdaqGS: LBAI) stock or $11.35 in cash for each share owned.
LBAI: 11.44 (+0.30)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Pascack Bancorp, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Lakeland Bancorp, Inc. -- PSBR
PR Newswire - Wed Aug 05, 10:53AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
LBAI: 11.44 (+0.30)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Pascack Bancorp Concerning its Proposed Sale to Lakeland Bancorp, Inc.
BusinessWire - Tue Aug 04, 3:54PM CDT
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Pascack Bancorp (OTCSBR) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Pascack Bancorp to maximize shareholder value before agreeing to be acquired by Lakeland Bancorp, Inc. (NASDAQ:LBAI).
LBAI: 11.44 (+0.30)

Lakeland Bancorp to Acquire Pascack Bancorp
GlobeNewswire - Tue Aug 04, 7:41AM CDT
The Boards of Directors of Lakeland Bancorp, Inc. (NASDAQ:LBAI) ("Lakeland Bancorp", the parent company of Lakeland Bank, and Pascack Bancorp, Inc. (OTCQXSBR) ("Pascack Bancorp", the parent company of Pascack Community Bank, announced today that the companies have entered into a definitive Agreement and Plan of Merger (the "Merger Agreement", pursuant to which Pascack Bancorp will be merged with and into Lakeland Bancorp, with Lakeland Bancorp as the surviving bank holding company, and Pascack Community Bank will merge with and into Lakeland Bank, with Lakeland Bank as the surviving bank. The Merger Agreement provides that shareholders of Pascack Bancorp will receive, at their election, for each outstanding share of Pascack Bancorp common stock that they own at the effective time of the merger or would own upon conversion of preferred stock immediately prior to such effective time, either 0.9576 shares of Lakeland Bancorp common stock or $11.35 in cash, subject to proration as described in the Merger Agreement so that 90% of the aggregate merger consideration will be shares of Lakeland Bancorp common stock and 10% will be cash.
LBAI: 11.44 (+0.30)

OTC Markets Group Welcomes Pascack Bancorp, Inc. to OTCQX
PR Newswire - Wed Mar 25, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Pascack Bancorp, Inc. (OTCQX: PSBR), the holding company for Pascack Community Bank located in Waldwick, NJ, has qualified to trade on OTCQX®, the best marketplace for established, global and growth companies.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 17

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 311

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 35

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 0

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Preeclampsia: Key Insights for Expecting Parents

Updated Category News Views 46

Preeclampsia: Essential Insights for Expecting Parents Preeclampsia is a significant condition that often raises concerns among expecting parents. It manifests as a dangerous form of high blood pressure during pregnancy and can also surface postpartum. Understanding this condition is vital for ensuring the health and safety of both mother and child during this crucial...

Continue Reading
DTE Energy Enhances Reliability with Smart Grid Technology

Updated Category News Views 240

DTE Energy's Progress with Smart Grid Technology DTE Energy (NYSE:DTE) has announced impressive strides in enhancing energy reliability through its cutting-edge smart grid technology. This initiative has successfully prevented nearly 5,000 power interruptions and saved over 1.8 million outage minutes for customers this year, highlighting the technology's role in ensuring...

Continue Reading
Key Insider Transactions in Major US Companies Unveiled

Updated Category News Views 270

Significant Insider Trading Activities This article sheds light on the notable insider buying and selling events reported recently, reflecting the movements within major US stocks. Major Insider Purchases Berkshire Hathaway Inc. (NYSE: BRKa) has made headlines by increasing its stake in Verisign Inc. (NASDAQ: VRSN). Under the leadership of Warren E. Buffett, the company...

Continue Reading
Hull Tactical's Latest Research Paper Enhances Market Predictions

Updated Category News Views 135

Hull Tactical Releases Innovative Academic Research The Hull Tactical team is excited to unveil its latest academic paper, titled Micro Alphas, co-authored by a talented group including Blair Hull, Petra Bakosova, Francois Cocquemas, Euan Sinclair, and Petri Fast. This research introduces a fresh framework that focuses on utilizing weak yet collectively informative...

Continue Reading
Cyrano Therapeutics and KYORIN Join Forces for Smell Loss Treatment

Updated Category News Views 138

Cyrano Therapeutics and KYORIN Collaboration Overview Cyrano Therapeutics, a pioneer in regenerative medicine, has taken a significant step forward in addressing the challenge of post-viral loss of smell. The company has entered into an option agreement with KYORIN Pharmaceutical Co., Ltd. to develop CYR-064, a promising treatment candidate specifically designed for those...

Continue Reading